Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
dm199 (6 trials)
Cerebral Infarction (Phase 2)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Ischemia (Phase 2)
Kidney Diseases (Phase 2)
Renal Insufficiency, Chronic (Phase 2)
Stroke (Phase 2)
Trials (6 total)
Trial APIs (1 total)